Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03269032 · ClinicalTrials.gov registry record · NA

Mediterranean Diet and the Gut Microbiome

A NA study, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
10
Enrollment target

NCT03269032 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 10 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03269032, a NA study, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

This study will evaluate the impact of a Mediterranean-style diet on microbiome diversity compared to a typical American diet. The study will observe the microbiome composition comparisons in healthy volunteers as well as in patients with Irritable Bowel Syndrome with Diarrhea (IBS-D) to see if the consumption of a Mediterranean-style diet has a positive effect on improving symptoms of IBS-D.

Interventions

  • OTHER American Diet
  • OTHER Mediterranean-style Diet

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2017-10-10
Est. Completion 2021-01-01
Phase NA

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT03269032

The ClinicalTrials.gov registry entry for NCT03269032 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which American Diet is the first listed.

NCT03269032 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03269032 about?

NCT03269032 is a clinical study titled "Mediterranean Diet and the Gut Microbiome". This study will evaluate the impact of a Mediterranean-style diet on microbiome diversity compared to a typical American diet. The study will observe the microbiome composition comparisons in healthy volunteers as well as in patients with Irritable Bowel Syndrome with Diarrhea (IBS-D) to see if the ...

What is the current status of trial NCT03269032?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2017-10-10. Estimated completion is 2021-01-01.

What interventions are being tested in trial NCT03269032?

The interventions under investigation include: American Diet (OTHER), Mediterranean-style Diet (OTHER).

Who is sponsoring clinical trial NCT03269032?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.